Litcius/Paper detail

Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging–Guided Adaptive Prostate Radiation Therapy

Rosalyne Westley, Katie Biscombe, Alex Dunlop, Adam Mitchell, Uwe Oelfke, Simeon Nill, Julia Murray, Angela Pathmanathan, S. Hafeez, Chris Parker, Ragu Ratnakumaran, S. Alexander, Trina Herbert, Emma Hall, Alison Tree

2023International Journal of Radiation Oncology*Biology*Physics37 citationsDOI

Topics & Concepts

Common Terminology Criteria for Adverse EventsMedicineInterim analysisProstate cancerRadiation therapyToxicityClinical endpointAcute toxicityProstateMagnetic resonance imagingUrologyAdverse effectRandomized controlled trialOncologySurgeryInternal medicineRadiologyCancerProstate Cancer Diagnosis and TreatmentAdvanced Radiotherapy TechniquesMRI in cancer diagnosis
Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging–Guided Adaptive Prostate Radiation Therapy | Litcius